Skip to content
Trial Eligibility
Menu

ADRC Clinical Cohort (Alzheimer's Disease)

NCT06703541

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of the study is to establish a clinical cohort for the Duke/UNC Alzheimer's Disease Research Center (ADRC). The cohort will be composed of subjects ages 25 to 44 at enrollment with normal cognition and subjects ages 45 to 80 at enrollment with normal cognition, mild cognitive impairment, or a dementia diagnosis. Initial data including demographics, medical and family history, physical exam, and neuropsychological testing will be obtained. Participants will be asked to contribute a blood sample, a urine sample, a cerebrospinal fluid sample, and undergo a MRI scan.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alzheimer Disease
  • Mild Cognitive Impairment
  • Dementia

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
25 to 80 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Duke University
Last updated on ClinicalTrials.gov
September 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

North Carolina · 1

  • Duke University · Durham, NC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.